KURT, A. Et Al. 2012. Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation. BMC CLINICAL PATHOLOGY , vol.12 .

KURT, A., YANAR, F., Asoglu, O., Balik, E., Olgac, V., Karanlik, H., ... Kucuk, S. T.(2012). Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation. BMC CLINICAL PATHOLOGY , vol.12.

KURT, ATİLLA Et Al. "Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation," BMC CLINICAL PATHOLOGY , vol.12, 2012

KURT, ATİLLA Et Al. "Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation." BMC CLINICAL PATHOLOGY , vol.12, 2012

KURT, A. Et Al. (2012) . "Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation." BMC CLINICAL PATHOLOGY , vol.12.

@article{article, author={ATİLLA KURT Et Al. }, title={Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation}, journal={BMC CLINICAL PATHOLOGY}, year=2012}